|
|
Collaborators
|
||||||||||
|
L Agodoa (Bethesda, USA) |
S MacMahon (Sydney, Australia) E Malacco (Milan, Italy) G Mancia (Monza, Italy) B Neal (Sydney, Australia) S Nissen (Cleveland, USA) C Pepine (Gainsville, USA) M Pfeffer (Boston, USA) B Pitt (Ann Arbor, USA) P Poole-Wilson (London, UK) C Reid (Melbourne, Australia) G Remuzzi (Bergamo, Italy) A Rodgers (Auckland, New Zealand) P Ruggenenti (Bergamo, Italy) R Schrier (Denver, USA) P Sever (London, UK) P Sleight (Oxford, UK) J Staessen (Leuven, Belgium) K Teo (Edmonton, Canada) G Viberti (London, UK) J Wang (Shanghai, China) P Whelton (New Orleans, USA) L Wing (Adelaide, Australia) Y Yui (Kyoto, Japan) S Yusuf (Hamilton, Canada) A Zanchetti (Milan, Italy) |
Address: Contact person: Coordinating Centre Staff: |
|
L Agodoa (NIH, Bethesda)C Baigent (CTSU, Oxford) B Brenner (Boston) A Cass (GI, Sydney) M Gallagher (GI, Sydney) L Hunsicker (Lowa) P Kearney (CTSU, Oxford) V Perkovic (GI, Sydney) K Wilson (CTSU, Oxford) |
|
FundingThe Collaboration
has received funding from both grant awarding bodies and the pharmaceutical
industry. The collection, management, analysis and interpretation of the data;
and the preparation, review and approval of manuscripts are supported by peer-reviewed
funding (see Grant Awarding Bodies). Meetings of collaborators are supported by
educational grants from Industry (see Sponsoring Pharmaceutical Companies). Grant
Awarding Bodies National
Health and Medical Research Council of Australia, National Heart
Foundation of Australia, Health Research Council of New Zealand,
British Heart Foundation, International Society of Hypertension Sponsoring
Pharmaceutical Companies AstraZeneca, Aventis Pharmaceuticals, Bayer AG, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline SpA, Hoechst AG, Merck, Pfizer Inc., Pharmacia, Searle, Servier International, Solvay. |
|

Background | Methods | Collaboration | Results | Resources | Future